Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

Published:2010-03 Issue:2 Volume:40 Page:78-88
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Kwekkeboom Dik J.,de Herder Wouter W.,van Eijck Casper H.J.,Kam Boen L.,van Essen Martijn,Teunissen Jaap J.M.,Krenning Eric P.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference68 articles.

1. Localization of endocrine related tumors with radioiodinated analogue of somatostatin;Krenning;Lancet,1989

2. Gastroenteropancreatic endocrine tumours: Effect of Sandostatin on tumour growth;Arnold;Digestion,1993

3. Long-term management of the carcinoid syndrome;Janson;Acta Oncol,1993

4. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors;Ducreux;Am J Gastroenterol,2000

5. Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The Rotterdam experience;Valkema;Semin Nucl Med,2002

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide Receptor Radionuclide Therapy (PRRT);Neuroendocrine Tumours;2024

2. A clinical perspective on ectopic Cushing’s syndrome;Trends in Endocrinology & Metabolism;2023-12

3. Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE;Journal of Gastrointestinal Oncology;2023-06

4. Should peptide receptors radionuclide therapy (PRRT) be considered as a treatment of choice in functioning metastatic insulinomas? A review of literature and our center experience;Clinical and Translational Imaging;2022-03-26

5. Quality Assurance in SPECT/CT for Radionuclide Therapy with Lutetium-177;International Journal of Medical Physics, Clinical Engineering and Radiation Oncology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3